January 29, 2018 / 1:15 PM / 9 months ago

BRIEF-Rexahn Pharma Receives Notice Of Allowance For New U.S. Patent

Jan 29 (Reuters) - Rexahn Pharmaceuticals Inc:

* REXAHN PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR A NEW U.S. PATENT COVERING THE USE OF RX-5902 (SUPINOXIN™) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below